Jefferies analyst Glen Santangelo lowered the price target on Collegium Pharmaceutical (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Collegium Pharma (COLL) Tops Q3 EPS by 4cNovember 7, 2024 4:55 PM Form 10-Q COLLEGIUM PHARMACEUTICAL For: Sep 30November 7, 2024 4:08 PM Collegium Pharma (COLL) Appoints Vikram Karnani as CEONovember 7, 2024 4:02 PM Form 8-K COLLEGIUM PHARMACEUTICAL For: Nov 06November 7, 2024 4:02 PM Collegium Reports Record Third Quarter 2024 Financial ResultsNovember 7, 2024 4:02 PM Collegium Appoints Vikram Karnani as Chief Executive OfficerNovember 7, 2024 4:01 PM